WallStreetZenWallStreetZen

NASDAQ: PRPH
Prophase Labs Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for PRPH

Based on 1 analyst offering 12 month price targets for Prophase Labs Inc.
Min Forecast
$14.00+37.8%
Avg Forecast
$14.00+37.8%
Max Forecast
$14.00+37.8%

Should I buy or sell PRPH stock?

Based on 2 analysts offering ratings for Prophase Labs Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PRPH stock forecasts and price targets.

PRPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 5%
96
BuyMaintains$14.00+37.80%2022-05-17
Dawson James
Bottom 7%
7
HoldDowngradesN/AN/A2021-10-13

1 of 1

Forecast return on equity

Is PRPH forecast to generate an efficient return?
Company
21.37%
Industry
21.21%
Market
118.57%
PRPH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PRPH forecast to generate an efficient return on assets?
Company
14.87%
Industry
13.72%
PRPH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PRPH earnings per share forecast

What is PRPH's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.15-33.53%
Avg 2 year Forecast
$0.12-93.06%
Avg 3 year Forecast
$0.78-54.91%
PRPH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

PRPH revenue forecast

What is PRPH's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$62.5M-52.35%
Avg 2 year Forecast
$47.9M-63.54%
Avg 3 year Forecast
$55.8M-57.49%
PRPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PRPH earnings growth forecast

How is PRPH forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
-23.32%
Industry
15.91%
Market
16.42%
PRPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
PRPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
PRPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

PRPH revenue growth forecast

How is PRPH forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
-24.81%
Industry
6.06%
Market
8.46%
PRPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PRPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PRPH vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
PRPH$10.16$14.00+37.80%Buy
INCR$4.23$11.50+171.87%Strong Buy
BGXX$1.25N/AN/A
IXHL$4.81N/AN/A
KMDA$4.50$11.00+144.44%Strong Buy

Prophase Labs Stock Forecast FAQ

Is Prophase Labs Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: PRPH) stock is to Buy PRPH stock.

Out of 2 analysts, 0 (0%) are recommending PRPH as a Strong Buy, 1 (50%) are recommending PRPH as a Buy, 1 (50%) are recommending PRPH as a Hold, 0 (0%) are recommending PRPH as a Sell, and 0 (0%) are recommending PRPH as a Strong Sell.

If you're new to stock investing, here's how to buy Prophase Labs stock.

What is PRPH's earnings growth forecast for 2022-2024?

(NASDAQ: PRPH) Prophase Labs's forecast annual earnings growth rate of -23.32% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 15.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.42%.

Prophase Labs's earnings in 2022 is $26,551,000.On average, 1 Wall Street analyst forecast PRPH's earnings for 2022 to be $18,407,155, with the lowest PRPH earnings forecast at $18,407,155, and the highest PRPH earnings forecast at $18,407,155. On average, 2 Wall Street analysts forecast PRPH's earnings for 2023 to be $1,920,747, with the lowest PRPH earnings forecast at -$7,843,049, and the highest PRPH earnings forecast at $11,684,542.

In 2024, PRPH is forecast to generate $12,484,853 in earnings, with the lowest earnings forecast at $12,484,853 and the highest earnings forecast at $12,484,853.

What is PRPH's revenue growth forecast for 2022-2024?

(NASDAQ: PRPH) Prophase Labs's forecast annual revenue growth rate of -24.81% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.06%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.46%.

Prophase Labs's revenue in 2022 is $131,252,000.On average, 2 Wall Street analysts forecast PRPH's revenue for 2022 to be $1,001,109,155, with the lowest PRPH revenue forecast at $265,223,099, and the highest PRPH revenue forecast at $1,736,995,211. On average, 2 Wall Street analysts forecast PRPH's revenue for 2023 to be $765,977,754, with the lowest PRPH revenue forecast at $715,478,123, and the highest PRPH revenue forecast at $816,477,384.

In 2024, PRPH is forecast to generate $893,147,188 in revenue, with the lowest revenue forecast at $893,147,188 and the highest revenue forecast at $893,147,188.

What is PRPH's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: PRPH) forecast ROA is 14.87%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 13.72%.

What is PRPH's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PRPH price target, the average PRPH price target is $14.00, with the highest PRPH stock price forecast at $14.00 and the lowest PRPH stock price forecast at $14.00.

The Wall Street analyst predicted that Prophase Labs's share price could reach $14.00 by May 17, 2023. The average Prophase Labs stock price prediction forecasts a potential upside of 37.8% from the current PRPH share price of $10.16.

What is PRPH's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: PRPH) Prophase Labs's current Earnings Per Share (EPS) is $1.73. On average, analysts forecast that PRPH's EPS will be $1.15 for 2022, with the lowest EPS forecast at $1.15, and the highest EPS forecast at $1.15. On average, analysts forecast that PRPH's EPS will be $0.12 for 2023, with the lowest EPS forecast at -$0.49, and the highest EPS forecast at $0.73. In 2024, PRPH's EPS is forecast to hit $0.78 (min: $0.78, max: $0.78).

What is PRPH's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: PRPH) forecast ROE is 21.37%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.